Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., compds. with triethanolamine

Endpoint summary

Description of key information

LAS TEA:

In a reliable in vivo skin sensitisation study conducted according to the OECD 406 guideline (Buehler), the substance (59.2% solution in water) was administered to guinea pigs, epicutaneously. The results demonstrated that the substance is not a skin sensitiser.

Supporting information on analogues

LAS Na:

In a reliable in vivo skin sensitisation study conducted according to OECD 406 guideline the substance (25% solution) was administered to 10 male and 10 female guinea pigs via an intradermal injection. One week later, a second induction was performed, i.e. another dermal exposure to 25% test solution for 24 hrs. On day 21, the challenge exposure was performed. All animals were exposed to 12.5% test solution dermally. Exposure was for 24 hrs, with observations made at 48 and 72 hrs after the start of exposure. No positive reactions were noted. The test substance is not a skin sensitiser..

TEA:

The sensitising potential of TEA was investigated in a Guinea Pig Maximisation Test according to OECD TG 406 under GLP conditions (Hoechst, 1988). Based on the results of a pre-test, animals were dermally injected twice with 0.1 mL 2% TEA on day 1, followed by an epicutaneous induction (occlusive) with 0.5 mL undiluted TEA for 48 hours starting on day 9, and a dermal challenge (occlusive) with 0.5 mL 10% TEA for 24 hours on day 22. Dermal reactions were evaluated according to Draize 48 and 72 hours after the start of the dermal challenge. No clinical signs were noticed and all readings were negative.

Regarding the available human data, the positive reactions interpreted as allergic seem to be caused by exposure to TEA in cosmetics and/or topical therapeutic preparations possibly on damaged skin. The diagnosis of TEA contact sensitisation should therefore not be based on a positive patch test reaction alone but on a combination of history and preferably validation tests.

The negative experimental findings in animals and the level of exposure to TEA in the population, together with the low frequency of positive reactions to low TEA concentrations in patch-tested patients indicate a very low sensitisation potential in humans, and the risk of sensitisation to TEA on uncompromised skin seems to be very low (Lessmann, 2009).

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Endpoint:

skin sensitisation: in vivo (non-LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

6 February 1995 - 5 April 1995

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 406 (Skin Sensitisation)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Type of study:

Buehler test

Justification for non-LLNA method:

An in vivo study conducted to GLP and following an OECD Guideline methodology is available. Given that it is reliable (Klimisch 1) this study is considered to be satisfactory to assess the sensitisation potential of the substance.

Species:

guinea pig

Strain:

Dunkin-Hartley

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: Harlan Winkelmann GmbH
- Age at study initiation: young adult females
- Weight at study initiation: less than 500 g
- Housing: Makrolon cages Type IV (max. 5 animals per cage)
- Diet: Ssniff G 4- complete diet food for guinnea pigs, ad libitum
- Water: tap water, ad libitum
- Acclimation period:at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ±3
- Humidity (%): 30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES:
- Pre-test: From: 06.02.1995 To: 09.02.1995
- Main test: From: 06.03.1995 To: 05.04.1995

Route:

epicutaneous, occlusive

Vehicle:

water

Concentration / amount:

59.2%

Day(s)/duration:

6 hrs

No.:

#1

Route:

epicutaneous, occlusive

Vehicle:

water

Remarks:

demineralised

Concentration / amount:

20%

Day(s)/duration:

6 hrs

No. of animals per dose:

Range finding tests: 3 animals were used for establishing the induction concentration, 3 animals for establishing the challenge concentration
Main test: 20 animals in the test group (one dose) and 10 animals in the control group

Details on study design:

RANGE FINDING TESTS:
Pilot study for establishing the concentration used for each induction exposure:
- Test concentrations: 5.0, 20.0, 40.0 and 59.2% (w/w) Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine (CAS no. 68411-31-4) in demineralised water
- Exposure period: 6 hours
- No. of exposures: 1
- Replica's: 3 (the posterior, anterior, left and right flank of each of three animals were used for the four different test concentrations)
- Evaluation (hr after start application): 30 and 54 h

Pilot study for establishing the concentration used for the challenge exposure (performed in the fourth week of the main test):
- Test concentrations: 5, 20, 40 and 50% (w/w) Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine (CAS no. 68411-31-4) in demineralised water
- Exposure period: 6 hours
- No. of exposures: 1
- Replica's: 3 (the posterior, anterior, left and right flank of each of three animals were used for the four different test concentrations)
- Evaluation (hr after start application): 30 and 54 h

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: three
- Exposure period: 6 h
- Test groups: one test group (20 animals) induction with 59.2% Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine (CAS no. 68411-31-4) (pure product MARLOPON AT 50)
- Control group: 10 animals, induction with vehicle (demineralised water)
- Site: left flank previously shaved
- Frequency of applications: Induction phase I: Day 0, induction phase II: Day 7, induction phase III: Day 14
The dermal reaction was assessed 30 h after the application,
- Concentrations: vehicle only or 59.2% Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine (CAS no. 68411-31-4) (pure product MARLOPON AT 50)


B. CHALLENGE EXPOSURE
- No. of exposures: one
- Day(s) of challenge: Day 28
- Exposure period: 6 h
- Test groups: one test group (20 animals)
- Control group: 10 animals
- Site: right flank previous shaved
- Concentrations: 20% Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine (CAS no. 68411-31-4) or vehicle only
- Evaluation (hr after challenge): 30 and 54 h

OTHER:

Positive control substance(s):

yes

Remarks:

2-Mercaptobenzothiazole(2-MCBT), in a seperate test

Positive control results:

A positive skin response (irritation scored as erythema, scaling and oedema) was observed in 90% of the test animals challenged with 50% 2-MCBT, and in 5-10% of the test animals challenged with vehicle, compared to 0% response in the control group (both for the challenge with 50% 2-MCBT and vehicle). Therefore, it can be concluded that the sensitivity of the guinea pigs is sufficient.

Key result

Reading:

1st reading

Hours after challenge:

30

Group:

test chemical

Dose level:

20%

No. with + reactions:

2

Total no. in group:

20

Clinical observations:

very slight erythema and oedema

Remarks on result:

other: Reading: 1st reading. . Hours after challenge: 30.0. Group: test group. Dose level: 20%. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: very slight erythema and oedema.

Key result

Reading:

2nd reading

Hours after challenge:

54

Group:

test chemical

Dose level:

20%

No. with + reactions:

2

Total no. in group:

20

Clinical observations:

very slight erythema and slight oedema

Remarks on result:

other: Reading: 2nd reading. . Hours after challenge: 54.0. Group: test group. Dose level: 20%. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: very slight erythema and slight oedema.

Reading:

1st reading

Hours after challenge:

30

Group:

test chemical

Dose level:

vehicle

No. with + reactions:

1

Total no. in group:

20

Clinical observations:

very slight erythema and oedema in animal 11

Remarks on result:

other: Reading: 1st reading. . Hours after challenge: 30.0. Group: test group. Dose level: vehicle. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: very slight erythema and oedema in animal 11.

Reading:

2nd reading

Hours after challenge:

54

Group:

test chemical

Dose level:

vehicle

No. with + reactions:

1

Total no. in group:

20

Clinical observations:

very slight erythema and oedema in animal 1 (none in animal 11)

Remarks on result:

other: Reading: 2nd reading. . Hours after challenge: 54.0. Group: test group. Dose level: vehicle. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: very slight erythema and oedema in animal 1 (none in animal 11).

Reading:

1st reading

Hours after challenge:

30

Group:

negative control

Dose level:

20%

No. with + reactions:

1

Total no. in group:

10

Clinical observations:

very slight erythema and oedema

Remarks on result:

other: Reading: 1st reading. . Hours after challenge: 30.0. Group: negative control. Dose level: 20%. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: very slight erythema and oedema.

Reading:

2nd reading

Hours after challenge:

54

Group:

negative control

Dose level:

20%

No. with + reactions:

0

Total no. in group:

10

Clinical observations:

none

Remarks on result:

other: Reading: 2nd reading. . Hours after challenge: 54.0. Group: negative control. Dose level: 20%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.

Reading:

1st reading

Hours after challenge:

30

Group:

negative control

Dose level:

vehicle

No. with + reactions:

0

Total no. in group:

10

Clinical observations:

none

Remarks on result:

other: Reading: 1st reading. . Hours after challenge: 30.0. Group: negative control. Dose level: vehicle. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.

Reading:

2nd reading

Hours after challenge:

54

Group:

negative control

Dose level:

vehicle

No. with + reactions:

0

Total no. in group:

10

Clinical observations:

none

Remarks on result:

other: Reading: 2nd reading. . Hours after challenge: 54.0. Group: negative control. Dose level: vehicle. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.

Reading:

1st reading

Hours after challenge:

48

Group:

positive control

Dose level:

50%

No. with + reactions:

9

Total no. in group:

10

Clinical observations:

Erythema (with scab formation) and oedema

Remarks on result:

positive indication of skin sensitisation

Reading:

2nd reading

Hours after challenge:

72

Group:

positive control

Dose level:

50%

No. with + reactions:

9

Total no. in group:

10

Clinical observations:

Erythema (with scab formation) and oedema

Remarks on result:

positive indication of skin sensitisation

Range finding tests:

Pre-test for establishing the induction concentration:

The 5 and 20% test concentrations did not result in skin irritation in any of the animals. One animal did not repsond to any of the test concentrations. One animal responded to the 40 and 59.2% test concentration after 30 hours with hardly visible erythema which had disappeared at the 54 hour observation. One animal responded to the 59.2% test concentration at both 30 and 54 hour interval with a very slight red discoloration of the skin.

The 59.2% test concentration was chosen for the induction phase as the highest test concentation causing slight to mild irritation.

Pre-test for establishing the induction concentration:

No skin irritation was observed in any of the three test animals tested at 5, 20, 40 and 50% test concentration. Because of the increasing skin irritation over the course of the trhee induction phases from slight to severe skin irritation, combined with the observation of slight skin irritation in one animal exposed to 40% test concentration in the first pre-test, it was decided to use the 20% test concentration as challenge treatment in the main test.

Main test:

During the study no systemic effects or effects on body weight were observed in animals from both the test and control group.

The dermal application during induction phase I resulted after 30 hours in skin irritation in 11 out of 20 test animals consisting of very sligth erythema, in 5 animals this additionally hardly noticable oedema was observed. Further, occasionally dry skin, scaling and scratches at the application site were observed. Nine test animals and all control animals showed no skin irritation.

Thirty hours after application in induction phase II all test animals showed well-defined erythema and oedema, and in 14 animals also dry skin was observed at the application site. The control animals showed no skin irritation.

At the shaving before the third induction apllication scaling of the skin at the application sites was observed in all test animals. Thirty hours after the third application all test animals showed well-defined to severe erythema and oedema, in three animals associated with scaling, in eight animals with necrotic patches and three animals showed clear necroses at the application site. The control animals showed no skin irritation.

The challenge with 20% Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine (CAS no. 68411-31-4) resulted at 30 and 54 hours after application in a skin respons in 2 out of 20 animals. The response consisted of very slight erythema and oedema, and in one animal the oedema was slightly increased after 54 hours. One control animal showed after 30 hours also a hardly visible red discoloration of the skin at the application site of the 20% test solution. The remaining animals (18 test anmals and 9 control animals) showed no signs of irritation (erythema or oedema) at the application site treated with 20% test solution.

The challenge with vehicle (water) did not result in a skin reaction at 18 test animals and all 10 control animals. One test animals showed hardly visible irritation of the skin after 30 hours, whereas another test animals showed this respons after 54 hours.

Summary table:

	Number of animals with skin response at x hours after application				Total number of animals with skin response
	30 hours		54 hours		30 and 54 hours
	20% TS	Vehicle	20% TS	Vehicle	20% TS	Vehicle
	E / O	E / O	E / O	E / O	E / O	E / O
Control group (n = 10)	1 / 0	0 / 0	0 / 0	0 / 0	1 / 0	0 / 0
Test group (n = 20)	2 / 2	1 / 1	2 / 2	1 / 1	2 / 2	2 / 2

TS = Test substance (Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine (CAS no. 68411-31-4))

E = Erythema and Eschar formation

O = Oedema formation

Interpretation of results:

GHS criteria not met

Conclusions:

Based on the results of a reliable Buehler study (OECD 406) the substance is not a skin sensitiser.

Executive summary:

In a dermal sensitisation study with the substance in water, young adult guinea pigs (20 females in test group, 10 in control group) were tested using the method of Buehler according to OECD 406 (59.2% and 20% substance concentration in induction and challenge phase, respectively). Water was used as vehicle control and 2 -Mercaptobenzothiazol was used as positive control.

The dermal application during induction phase I after 30 hr resulted in skin irritation in 11/20 animals consisting of very slight erythema, in 5 animals hardly noticeable oedema. Further, occasionally dry skin, scaling and scratches at the application site were observed. Thirty hours after application in induction phase II all test animals showed well-defined erythema and oedema, and in 14 animals also dry skin was observed at the application site. At the shaving before the 3rd induction, scaling of the skin at the application site was observed in all test animals. Thirty hours after the 3rd application all test animals showed well-defined to severe erythema and oedema, in 3 animals associated with scaling, in 8 animals with necrotic patches and 3 animals showed clear necrosis at the application site. The challenge with substance resulted in a skin response in 2 out of 20 animals at 30 and 54 h post-application. The response consisted of very slight erythema and oedema, and in one animal the oedema was slightly increased after 54 h. One control animal showed also showed a hardly visible red discoloration of the skin at the application site of the 20% test solution after 30 h. The remaining animals (18 test and 9 control) showed no signs of irritation at the application site treated with 20% test solution. The challenge with vehicle (water) did not result in a skin reaction in 18 test and all control animals. One test animal showed hardly visible irritation of the skin after 30 h, whereas another test animals showed this response after 54 h.

For both the challenge with vehicle (water) as well as with substance 10% of the animals responded with light skin irritation. Therefore, the substance is considered to have no skin sensitisation potential.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not sensitising)

Additional information:

One study is available on the substance itself as well as one study on each of two analogues. All studies were negative.

Respiratory sensitisation

Endpoint conclusion

Endpoint conclusion:

no study available

Justification for classification or non-classification

Based on the results of reliable in vivo studies conducted on the substance and on two analogues, the substance is not classified.